Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Epigenetics of epithelial-to-mesenchymal transition in pancreatic carcinoma
Max M. Träger, Sameer A. Dhayat
International Journal of Cancer (2017) Vol. 141, Iss. 1, pp. 24-32
Open Access | Times Cited: 32

Showing 1-25 of 32 citing articles:

EMT: Present and future in clinical oncology
Patricia G. Santamarı́a, Gema Moreno‐Bueno, Francisco Portillo, et al.
Molecular Oncology (2017) Vol. 11, Iss. 7, pp. 718-738
Open Access | Times Cited: 220
Oncogene c-Myc promotes epitranscriptome m6A reader YTHDF1 expression in colorectal cancer
Yujiro Nishizawa, Masamitsu Konno, Ayumu Asai, et al.
Oncotarget (2017) Vol. 9, Iss. 7, pp. 7476-7486
Open Access | Times Cited: 206
LncRNA HOTAIR acts as competing endogenous RNA to control the expression of Notch3 via sponging miR-613 in pancreatic cancer
Huihua Cai, Jie Yao, Yong An, et al.
Oncotarget (2017) Vol. 8, Iss. 20, pp. 32905-32917
Open Access | Times Cited: 90
Drug Resistance in Cancer Therapy and the Role of Epigenetics
Takeshi Asano
Journal of Nippon Medical School (2020) Vol. 87, Iss. 5, pp. 244-251
Open Access | Times Cited: 61
Potential of Exosomal microRNA-200b as Liquid Biopsy Marker in Pancreatic Ductal Adenocarcinoma
Moritz Reese, Isabelle Flammang, Zixuan Yang, et al.
Cancers (2020) Vol. 12, Iss. 1, pp. 197-197
Open Access | Times Cited: 51
Functional Role of Non-Coding RNAs during Epithelial-To-Mesenchymal Transition
Almudena Expósito-Villén, Amelia Aránega, Diego Franco
Non-Coding RNA (2018) Vol. 4, Iss. 2, pp. 14-14
Open Access | Times Cited: 58
Role of exosomal microRNA-125b-5p in conferring the metastatic phenotype among pancreatic cancer cells with different potential of metastasis
Mengwei Wu, Xiaodong Tan, Peng Liu, et al.
Life Sciences (2020) Vol. 255, pp. 117857-117857
Closed Access | Times Cited: 48
Cell‐Released Magnetic Vesicles Capturing Metabolic Labeled Rare Circulating Tumor Cells Based on Bioorthogonal Chemistry
Ke Kang, Xiaoxi Zhou, Yujia Zhang, et al.
Small (2021) Vol. 17, Iss. 18
Closed Access | Times Cited: 32
Novel agents for pancreatic ductal adenocarcinoma: emerging therapeutics and future directions
Yiyin Zhang, Chao Yang, Cheng He, et al.
Journal of Hematology & Oncology (2018) Vol. 11, Iss. 1
Open Access | Times Cited: 33
Potential application of cell reprogramming techniques for cancer research
Shigeo Saito, Ying‐Chu Lin, Yukio Nakamura, et al.
Cellular and Molecular Life Sciences (2018) Vol. 76, Iss. 1, pp. 45-65
Open Access | Times Cited: 33
Suppression of Esophageal Squamous Cell Carcinoma Development by Mechanosensitive Protein Piezo1 Downregulation
Lu Gao, Yun Ji, Lulu Wang, et al.
ACS Omega (2021) Vol. 6, Iss. 15, pp. 10196-10206
Open Access | Times Cited: 27
Regulation of epithelial-mesenchymal transition by protein lysine acetylation
Fanyun Kong, Lihong Ma, Xing Wang, et al.
Cell Communication and Signaling (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 18
Clinical impact of different exosomes’ protein expression in pancreatic ductal carcinoma patients treated with standard first line palliative chemotherapy
Riccardo Giampieri, Francesco Piva, Giulia Occhipinti, et al.
PLoS ONE (2019) Vol. 14, Iss. 5, pp. e0215990-e0215990
Open Access | Times Cited: 29
Next-generation paclitaxel-nanoparticle formulation for pancreatic cancer treatment
Andrew E. Massey, Mohammed Sikander, Neeraj Chauhan, et al.
Nanomedicine Nanotechnology Biology and Medicine (2019) Vol. 20, pp. 102027-102027
Open Access | Times Cited: 27
Comprehensive transcriptome profiling in elderly cancer patients reveals aging‐altered immune cells and immune checkpoints
Yingcheng Wu, Jinhuan Wei, Xia Chen, et al.
International Journal of Cancer (2018) Vol. 144, Iss. 7, pp. 1657-1663
Closed Access | Times Cited: 24
Cancer epigenetics in solid organ tumours: A primer for surgical oncologists
Thomas M Drake, Kjetil Søreide
European Journal of Surgical Oncology (2019) Vol. 45, Iss. 5, pp. 736-746
Open Access | Times Cited: 22
Research Progress of Pancreas-Related Microorganisms and Pancreatic Cancer
Wenqing Zhang, Xiaoying Zhang, Peng Zhang, et al.
Frontiers in Oncology (2021) Vol. 10
Open Access | Times Cited: 17
Clinical Impact of Epithelial-to-Mesenchymal Transition Regulating MicroRNAs in Pancreatic Ductal Adenocarcinoma
Sameer A. Dhayat, Max Michael Traeger, Jan Rehkaemper, et al.
Cancers (2018) Vol. 10, Iss. 9, pp. 328-328
Open Access | Times Cited: 19
<p>Is there a CDKN2A-centric network in pancreatic ductal adenocarcinoma?</p>
Chu Wu, Ping Yang, Bingxue Liu, et al.
OncoTargets and Therapy (2020) Vol. Volume 13, pp. 2551-2562
Open Access | Times Cited: 17
MicroRNA‐148a‐3p suppresses epithelial‐to‐mesenchymal transition and stemness properties via Wnt1‐mediated Wnt/β‐catenin pathway in pancreatic cancer
Xiaowei Fu, Le Van Hong, Zhengjiang Yang, et al.
Journal of Cellular and Molecular Medicine (2020) Vol. 24, Iss. 22, pp. 13020-13035
Open Access | Times Cited: 16
Epigenetic regulation of epithelial to mesenchymal transition: a trophoblast perspective
Jaganmoy Choudhury, Deepak Pandey, Pradeep Kumar Chaturvedi, et al.
Molecular Human Reproduction (2022) Vol. 28, Iss. 5
Closed Access | Times Cited: 9
The ambiguous role of microRNA-205 and its clinical potential in pancreatic ductal adenocarcinoma
Max Michael Traeger, Jan Rehkaemper, Hansjoerg Ullerich, et al.
Journal of Cancer Research and Clinical Oncology (2018) Vol. 144, Iss. 12, pp. 2419-2431
Closed Access | Times Cited: 15
miRNA-193b-5p Suppresses Pancreatic Cancer Cell Proliferation, Invasion, Epithelial Mesenchymal Transition, and Tumor Growth by Inhibiting eEF2K
Nilgün Gürbüz, Nermin Kahraman, Hafize Elif Sonmez, et al.
Anti-Cancer Agents in Medicinal Chemistry (2022) Vol. 22, Iss. 14, pp. 2607-2618
Closed Access | Times Cited: 9
Targeting Epithelial Mesenchymal Plasticity in Pancreatic Cancer: A Compendium of Preclinical Discovery in a Heterogeneous Disease
James Monkman, Erik W. Thompson, Shivashankar H. Nagaraj
Cancers (2019) Vol. 11, Iss. 11, pp. 1745-1745
Open Access | Times Cited: 11
Knockdown of LRRN1 inhibits malignant phenotypes through the regulation of HIF-1α/Notch pathway in pancreatic ductal adenocarcinoma
Yalu Zhang, Qiaofei Liu, Sen Yang, et al.
Molecular Therapy — Oncolytics (2021) Vol. 23, pp. 51-64
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top